These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Metabolic syndrome, inflammation and atherothrombosis. Rohla M; Weiss TW Hamostaseologie; 2013; 33(4):283-94. PubMed ID: 23979637 [TBL] [Abstract][Full Text] [Related]
23. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass. Picardi A; Vespasiani-Gentilucci U Am J Gastroenterol; 2008 Dec; 103(12):3036-8. PubMed ID: 18853984 [TBL] [Abstract][Full Text] [Related]
24. Inflammation, the metabolic syndrome and cardiovascular risk. Tracy RP Int J Clin Pract Suppl; 2003 Mar; (134):10-7. PubMed ID: 12793593 [TBL] [Abstract][Full Text] [Related]
25. Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome. Izar MC; Fonseca HA; Pinheiro LF; Monteiro CM; Póvoa RM; Monteiro AM; Figueiredo-Neto AM; Gidlund MA; Fonseca FA Diab Vasc Dis Res; 2013 Jan; 10(1):32-9. PubMed ID: 22529217 [TBL] [Abstract][Full Text] [Related]
26. Statin loading for acute coronary syndromes. Nusca A; Melfi R; Patti G; Di Sciascio G Curr Opin Cardiol; 2010 Jul; 25(4):373-8. PubMed ID: 20520540 [TBL] [Abstract][Full Text] [Related]
27. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662 [TBL] [Abstract][Full Text] [Related]
28. [Inflammation and C-reactive protein in cardiovascular disease]. Munk PS; Larsen AI Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445 [TBL] [Abstract][Full Text] [Related]
29. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Kressel G; Trunz B; Bub A; Hülsmann O; Wolters M; Lichtinghagen R; Stichtenoth DO; Hahn A Atherosclerosis; 2009 Jan; 202(1):263-71. PubMed ID: 18501910 [TBL] [Abstract][Full Text] [Related]
30. Impact of the metabolic syndrome on high-sensitivity C reactive protein levels in patients with acute coronary syndrome. Kilic T; Jneid H; Ural E; Oner G; Sahin T; Kozdag G; Kahraman G; Ural D Atherosclerosis; 2009 Dec; 207(2):591-6. PubMed ID: 19577754 [TBL] [Abstract][Full Text] [Related]
35. Biomarkers, C-reactive proteins and statins in acute coronary syndromes. Ray KK Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():31-3. PubMed ID: 18001319 [TBL] [Abstract][Full Text] [Related]
36. [Non-alcoholic fatty liver disease: a new challenge for cardiologists]. Tarquini R; Lazzeri C; Boddi M; Marra F; Abbate R; Gensini GF G Ital Cardiol (Rome); 2010 Sep; 11(9):660-9. PubMed ID: 21348181 [TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome, inflammation and atherosclerosis - the role of adipokines in health and in systemic inflammatory rheumatic diseases. Santos MJ; Fonseca JE Acta Reumatol Port; 2009; 34(4):590-8. PubMed ID: 20852572 [TBL] [Abstract][Full Text] [Related]
38. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part I]. Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W Przegl Lek; 2006; 63(9):762-6. PubMed ID: 17479866 [TBL] [Abstract][Full Text] [Related]
39. CRP and the risk of atherosclerotic events. Calabrò P; Golia E; Yeh ET Semin Immunopathol; 2009 Jun; 31(1):79-94. PubMed ID: 19415283 [TBL] [Abstract][Full Text] [Related]
40. Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins. Toutouzas K; Drakopoulou M; Markou V; Karabelas I; Vaina S; Vavuranakis M; Tsiamis E; Tsioufis C; Androulakis A; Stefanadis C Int J Cardiol; 2007 Jul; 119(3):368-73. PubMed ID: 17258821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]